Evidence map›Paper›PMID 38661499›Full record

ReviewJournal of microscopy2025

Alexander Carsten, Antonio Virgilio Failla, Martin Aepfelbacher

Abstract readReviewEnglish Abstract
In one paragraph

Review in Journal of microscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Perspective: An outlook on fluorescence tracking.The Journal of chemical physics · 2025
    Article
  4. Article
  5. Journal of microscopy · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander CarstenInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg Eppendorf, Hamburg, Germany.ORCID 0000-0002-2701-5697
Antonio Virgilio FaillaUKE Microscopy Imaging Facility, University Medical Center Hamburg Eppendorf, Hamburg, Germany.ORCID 0000-0002-7137-0506
Martin AepfelbacherInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

Funding

European Regional Development Fund (ERDF) 51164232Joachim Herz Stiftung, Project Biomedical Physics of InfectionRTG 2771 Humans and Microbes
6 · The paper itself

Abstract

Since its introduction in 2017, MINFLUX nanoscopy has shown that it can visualise fluorescent molecules with an exceptional localisation precision of a few nanometres. In this overview, we provide a brief insight into technical implementations, fluorescent marker developments and biological studies that have been conducted in connection with MINFLUX imaging and tracking. We also formulate ideas on how MINFLUX nanoscopy and derived technologies could influence bioimaging in the future. This insight is intended as a general starting point for an audience looking for a brief overview of MINFLUX nanoscopy from theory to application.

Indexed as

NanotechnologyAnimalsFluorescent DyesHumansMicroscopy, FluorescenceFluorescent DyesMINFLUXsingle molecule trackingsuper‐resolution microscopy

Identifiers

PMID38661499
PMCPMC11987580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.